Reuters logo
BRIEF-CRISPR Therapeutics announces European patent for CRISPR/Cas gene editing
March 28, 2017 / 12:17 PM / 6 months ago

BRIEF-CRISPR Therapeutics announces European patent for CRISPR/Cas gene editing

March 28 (Reuters) - Crispr Therapeutics AG:

* CRISPR Therapeutics announces European patent for CRISPR/Cas gene editing

* CRISPR Therapeutics - patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below